APA (7th ed.) Citation

SP, P., J, F., YK, C., LS, S., A, K., B, K., . . . R, K. (2025). Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: Pancreatic neuroendocrine neoplasm (PNEN) cohort. Journal for immunotherapy of cancer, 13(6), . https://doi.org/10.1136/jitc-2025-011760

Chicago Style (17th ed.) Citation

SP, Patel, et al. "Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Pancreatic Neuroendocrine Neoplasm (PNEN) Cohort." Journal for Immunotherapy of Cancer 13, no. 6 (2025). https://doi.org/10.1136/jitc-2025-011760.

MLA (9th ed.) Citation

SP, Patel, et al. "Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Pancreatic Neuroendocrine Neoplasm (PNEN) Cohort." Journal for Immunotherapy of Cancer, vol. 13, no. 6, 2025, https://doi.org/10.1136/jitc-2025-011760.